Great update on the current secure trial.
very interesting to see they have now updated the protocol to include an expansion cohort of patients with an enzalutamide combination.
Novartis and Pluvicto just had amazing trial result with this combination
Ann: Clarity receives US FDA FTD for the treatment of mCRPC, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.38 |
Change
-0.280(6.01%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $4.62 | $4.65 | $4.30 | $18.54M | 4.185M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 14980 | $4.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.39 | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |